Substance / Medication

Isoflurophate

Overview

Active Ingredient
isoflurophate
RxNorm CUI
6027

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

136 trials linked to this intervention

136
Total Trials
11
Recruiting
53
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Visual Acuity Outcomes After Trans-scleral Cyclophotocoagulation: A Systematic Review and Meta-analysis.
Zajner Chris, Pandya Bhadra, Balas Michael et al. · Am J Ophthalmol · 2026
PMID: 40915521Meta-Analysis
Effectiveness and Accuracy of iCare HOME Tonometer in Glaucoma Patients: A Systematic Review.
Pons-Talaya Clara, Pons-Talaya Aina, Widmer Julia et al. · Am J Ophthalmol · 2026
PMID: 41110676Meta-Analysis
Can MicroRNAs Serve as Diagnostic Biomarkers for Glaucoma? A Systematic Review and Meta-analysis of Their Diagnostic Significance.
Chen Kai-Yang, Chan Hoi-Chun, Chan Chi-Ming · Mol Diagn Ther · 2026
PMID: 41454211Meta-Analysis
Latanoprost/timolol fixed-dose combination: two decades of efficacy and safety in glaucoma management.
Martinez-de-la-Casa Jose, Corsino Pedro, Grzybowski Andrzej et al. · BMC Ophthalmol · 2026
PMID: 41507838Meta-AnalysisFull text (PMC)
Iridoschisis associated with cataract: a systematic review of case reports.
Amaral Dillan Cunha, Rodrigues Márcio Penha Morterá, Marques Guilherme Nunes et al. · Einstein (Sao Paulo) · 2026
PMID: 41563299Meta-AnalysisFull text (PMC)
PreserFlo MicroShunt versus trabeculectomy: an updated meta-analysis and systematic review.
Governatori Lorenzo, Oliverio Leandro, Mermoud André et al. · Graefes Arch Clin Exp Ophthalmol · 2025
PMID: 39394492Meta-Analysis
GLP-1 Receptor Agonists Use and Incidence of Glaucoma: A Systematic Review and Meta-Analysis.
Amaral Dillan Cunha, Guedes Jaime, Cruz Matheus Ribeiro Barbosa et al. · Am J Ophthalmol · 2025
PMID: 39732312Meta-Analysis
Machine Learning Approaches in High Myopia: Systematic Review and Meta-Analysis.
Zuo Huiyi, Huang Baoyu, He Jian et al. · J Med Internet Res · 2025
PMID: 39753217Meta-AnalysisFull text (PMC)
Association between gene polymorphisms and glaucoma susceptibility among Africans: a systematic review and meta-analysis.
Asiamah Randy, Kyei Samuel, Owusu Paul et al. · Ophthalmic Genet · 2025
PMID: 39757584Meta-Analysis
Impact of Glaucoma Surgery on Corneal Graft Survival After Keratoplasty: A Systematic Review and Meta-Analysis.
Tawfik Abdelrahman M, Kasem Rawan A, Wesh Zeyad M et al. · J Glaucoma · 2025
PMID: 39841092Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Specialists

Providers who commonly manage this intervention

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Isoflurophate (substance)
SNOMED CT
373521002
UMLS CUI
C0022181
RxNorm CUI
6027

Clinical Data

This intervention maps to 5 entities in the Ltrl knowledge graph.

2
Conditions
1
Biomarkers
1
Specialists
0
Symptoms
136
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.